» Articles » PMID: 25569572

Well-ordered Trimeric HIV-1 Subtype B and C Soluble Spike Mimetics Generated by Negative Selection Display Native-like Properties

Overview
Journal PLoS Pathog
Specialty Microbiology
Date 2015 Jan 9
PMID 25569572
Citations 76
Authors
Affiliations
Soon will be listed here.
Abstract

The structure of BG505 gp140 SOSIP, a soluble mimic of the native HIV-1 envelope glycoprotein (Env), marks the beginning of new era in Env structure-based immunogen design. Displaying a well-ordered quaternary structure, these subtype A-derived trimers display an excellent antigenic profile, discriminating recognition by broadly neutralizing antibodies (bNAbs) from non-broadly neutralizing antibodies (non-bNAbs), and provide a solid Env-based immunogenic platform starting point. Even with this important advance, obtaining homogeneous well-ordered soluble SOSIP trimers derived from other subtypes remains challenging. Here, we report the "rescue" of homogeneous well-ordered subtype B and C SOSIP trimers from a heterogeneous Env mixture using CD4 binding site-directed (CD4bs) non-bNAbs in a negative-selection purification process. These non-bNAbs recognize the primary receptor CD4bs only on disordered trimers but not on the native Env spike or well-ordered soluble trimers due to steric hindrance. Following negative selection to remove disordered oligomers, we demonstrated recovery of well-ordered, homogeneous trimers by electron microscopy (EM). We obtained 3D EM reconstructions of unliganded trimers, as well as in complex with sCD4, a panel of CD4bs-directed bNAbs, and the cleavage-dependent, trimer-specific bNAb, PGT151. Using bio-layer light interferometry (BLI) we demonstrated that the well-ordered trimers were efficiently recognized by bNAbs and poorly recognized by non-bNAbs, representing soluble mimics of the native viral spike. Biophysical characterization was consistent with the thermostability of a homogeneous species that could be further stabilized by specific bNAbs. This study revealed that Env trimers generate different frequencies of well-ordered versus disordered aberrant trimers even when they are genetically identical. By negatively selecting the native-like well-ordered trimers, we establish a new means to obtain soluble Env mimetics derived from subtypes B and C for expanded use as candidate vaccine immunogens.

Citing Articles

Current methods for detecting and assessing HIV-1 antibody resistance.

Odidika S, Pirkl M, Lengauer T, Schommers P Front Immunol. 2025; 15():1443377.

PMID: 39835119 PMC: 11743526. DOI: 10.3389/fimmu.2024.1443377.


Exploring distinct modes of inter-spike cross-linking for enhanced neutralization by SARS-CoV-2 antibodies.

Nan X, Li Y, Zhang R, Wang R, Lv N, Li J Nat Commun. 2024; 15(1):10578.

PMID: 39632831 PMC: 11618796. DOI: 10.1038/s41467-024-54746-5.


mRNA lipid nanoparticles expressing cell-surface cleavage independent HIV Env trimers elicit autologous tier-2 neutralizing antibodies.

Guenaga J, Alirezaei M, Feng Y, Alameh M, Lee W, Baboo S Front Immunol. 2024; 15:1426232.

PMID: 39119336 PMC: 11306127. DOI: 10.3389/fimmu.2024.1426232.


Membrane HIV-1 envelope glycoproteins stabilized more strongly in a pretriggered conformation than natural virus Envs.

Zhang Z, Anang S, Nguyen H, Fritschi C, Smith 3rd A, Sodroski J iScience. 2024; 27(7):110141.

PMID: 38979012 PMC: 11228805. DOI: 10.1016/j.isci.2024.110141.


RAIN: machine learning-based identification for HIV-1 bNAbs.

Foglierini M, Nortier P, Schelling R, Winiger R, Jacquet P, ODell S Nat Commun. 2024; 15(1):5339.

PMID: 38914562 PMC: 11196741. DOI: 10.1038/s41467-024-49676-1.


References
1.
Zolla-Pazner S, deCamp A, B Gilbert P, Williams C, Yates N, Williams W . Vaccine-induced IgG antibodies to V1V2 regions of multiple HIV-1 subtypes correlate with decreased risk of HIV-1 infection. PLoS One. 2014; 9(2):e87572. PMC: 3913641. DOI: 10.1371/journal.pone.0087572. View

2.
Lyumkis D, Julien J, de Val N, Cupo A, Potter C, Klasse P . Cryo-EM structure of a fully glycosylated soluble cleaved HIV-1 envelope trimer. Science. 2013; 342(6165):1484-90. PMC: 3954647. DOI: 10.1126/science.1245627. View

3.
Yates N, Liao H, Fong Y, deCamp A, Vandergrift N, Williams W . Vaccine-induced Env V1-V2 IgG3 correlates with lower HIV-1 infection risk and declines soon after vaccination. Sci Transl Med. 2014; 6(228):228ra39. PMC: 4116665. DOI: 10.1126/scitranslmed.3007730. View

4.
Nkolola J, Cheung A, Perry J, Carter D, Reed S, Schuitemaker H . Comparison of multiple adjuvants on the stability and immunogenicity of a clade C HIV-1 gp140 trimer. Vaccine. 2014; 32(18):2109-16. PMC: 3980048. DOI: 10.1016/j.vaccine.2014.02.001. View

5.
Scharf L, Scheid J, Lee J, West Jr A, Chen C, Gao H . Antibody 8ANC195 reveals a site of broad vulnerability on the HIV-1 envelope spike. Cell Rep. 2014; 7(3):785-95. PMC: 4109818. DOI: 10.1016/j.celrep.2014.04.001. View